This week wasn't bad at all. A 3p drop in OPTI:Optibiotix following
more good news was frustrating but seems to be a regular occurrence. That
should have caused my portfolio to drop by £3,300 but it only fell by £1,910
showing just how well the other shares did. The deficit between cost and value
rose to £26,086 and sadly the total portfolio value dropped back below £100K
to £98,601.
Biggest losers were CMCL:Caledonia Mining and OPTI:Optibiotix,
both of which dropped 5% and both of which don't seem to have any reason for
the drop. They are both down by around 20% and I am terribly, terribly vexed.
Fortunately there were lots of big gains this week, with IES:Invinity Energy climbing 5% after announcing some new contracts and SAE:Simec Atlantis Energy also rising 5% but for no obvious reason.
PAY:Paypoint climbed 9% to go back in profit and above where they were when news broke of the competition law issues. They are 5% up now.
SBTX:SkinBioTherapeutics have been sliding since I bought them but did a reversal to climb 13% this week. They only need another 5% to be back in profit.
JLP:Jubilee Metals have been runner up for Share of the Week for the last 2 weeks despite making massive gains, but this week made another 18% and win the prize. They are now a wonderful 94% up on my purchase price and making £4,072 potential profit.
Just a tiny tick downwards.
It looks less tiny on here, but still just above the trend line.
The ISA and share accounts look like this
Weekly Change | |||
Cash |
£9.70 |
+£0 | |
Portfolio cost | £62,990.04 | +£0 | |
Portfolio sell value (bid price-commission) | £48,446.77 | (-23.1%) | -£1,350.95 |
Potential profits | £4,072.05 | +£800.00 | |
Yr 6 Dividends | £0 | +£0 | |
Yr 6 Profit from sales | £591.81 | +£0 | |
Yr 6 Average monthly cash profit | £156.22 | (3.0%) | -£10.41 |
Total Dividends | £1,343.15 | +£0 | |
Total Profit from sales | £21,018.42 | +£0 | |
Average monthly cash profit | £347.20 | (6.6%) | -£1.26 |
(Sold stocks profit + Dividends - Fees / Months) |
|||
Performance/Injection | 10.0% | +0% | |
Compound performance | 53% | +0% |
An annoying drop, but countered by a brilliant increase in potential profits of £800 as JLP:Jubilee Metals continues to soar. The rise has been on no news, so hopefully can only be boosted when expected news comes through on fine chrome processing starting again and the permission to process PGM tailings at DCM. There have been mutterings of current fair value being 9.5p, so there could be another 1p rise to come.
Nothing to worry about.
Still above the trend line.
The SIPP looks like this after week 260 and the end of year 5.
Weekly Change | ||||
Cash | £138.65 | +£0 | ||
Portfolio cost | £58,959.20 | +£0 | ||
Portfolio sell value (bid price - commission) |
£48,097.89 | (-18.4%) | -£631.56 | |
Potential profits | £1,050.54 | +£319.01 | ||
Yr 5 Dividends | £167.84 | +£0 | ||
Yr 5 Interest | £0.03 | +£0 | ||
Yr 5 Profit from sales | £2,910.34 | +£0 | ||
Yr 5 Average monthly cash profit | £241.72 | (4.9%) | -£4.74 | |
Total Dividends | £2,067.08 | +£0 | ||
Total Interest | £0.20 | +£0 | ||
Total Profit from sales | £15,459.44 | +£0 | ||
Average monthly cash profit | £281.76 | (5.7%) | -£1.09 | |
(Sold stocks profit + Dividends - Fees / Months) |
||||
Performance/Injection | 8.9% | +0% | ||
Compound performance | 45% | +0% |
A much smaller drop in value as so many shares did well this week, and there was much rejoicing when CAML:Central Asia Metals went back in profit despite having dividend ex-date for a 6p per share dividend worth £346. That will be a nice Christmas present.
Potential profits increased by £319 and £268 of that was CAML:Central Asia Metals. PAY:Paypoint also went back into profit, so there are now 6 shares in profit, with SBTX:SkinBioTherapeutics only down by 5% and the only magic formula share making a loss is CMCL:Caledonia Mining but I'm pretty certain that will turn around soon.
This was the last week of year 5 and my performance over the year in sales and dividends was an average of £241 a month. That's 4.9% of the current portfolio value, or more importantly 7.6% of the injection amount. It's below my long term average of £281 per month (8.9% of injection value), but still way better than any other type of savings account.
The profits were £905 from JLP:Jubilee Metals, £690 from
SBTX:SkinBioTherapeutics and £2,258 from DDDD:4D Pharma. I also
took a loss of £553 selling no-hopers N4P:N4 Pharma and £390 selling
MMX:Minds + Machines when red flags started waving furiously. Dividends
were negligible but contributed £167. That will be significantly boosted this
year as CAML:Central Asia Metals re-instate the dividend and the magic
formula shares get a full year paying them.
You can barely see the tick downwards
Just about above the trend line, but at least that's pointing upwards now.
The trading account looks like this after week 226
Weekly Change | |||
Cash | £236.18 | +£0 | |
Portfolio cost | £2,354.11 | +£0 | |
Portfolio sell value (bid price - commission) | £1,672.19 | (-29.0%) | +£71.58 |
Potential profits | £0 | +£0 | |
Year 5 Dividends | £0 | +£0 | |
Year 5 Profit | £370.12 | +£0 | |
Yr 5 Average monthly cash profit | £89.10 | (45.4%) | -£5.24 |
Dividends | £47.92 | +£0 | |
Profit from sales | £656.49 | +£0 | |
Average monthly cash profit | £13.51 | (6.9%) | -£0.06 |
(Sold stocks profit + Dividends - Fees / Months) |
A great week, especially thanks to the recovery in
SBTX:SkinBioTherapeutics. These are only 5% down now, so I may get to
reap another £100 soon. CAML:Central Asia Metals are the next closest
to profit, although still 25% down. I forgot until just now that I'll get £12
dividend from these next month. Every little helps! This account is making me
quite happy at the moment, as if I don't sell anything at all for the next 7
months, I'll still have made 15% this year. My long term performance will also
be good at 6% if I don't sell anything else. Hopefully I'll get to sell quite
a few things and these figures will be blown out of the water.
Well above the injection line and heading firmly towards the cost line.
The trend line is getting gradually steeper as the slow recovery continues.
Here's my wish list
- TLOU:Tlou Energy announce de-watering has resumed. Still no news, and there was a 2% pull back this week, but we remain hopeful.
- JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operational. Three weeks of massive gains and still this news hasn't dropped. At some point the profit taking will kick in, in fact it already has but the buying pressure is too great to prevent the upward momentum..
-
OPTI:Optibiotix to get within 10% of profit. Not really helped by a
5% drop this week. I'm keeping the wish though, as although 20% down, that
could be made back very quickly.
I'm running a little short on wishes. I guess the key one is CMCL:Caledonia Mining reverses the down trend and gets back into profit so all my magic formula shares will be in profit. Another new one will be SBTX:SkinBioTherapeutics gets back into profit, and that I can sell the ones in the trading account.
I was looking at my shares account, as it's where the trading account shares live. It also houses 3,965 OPTI:Optibiotix shares which I bought hoping to make a quick return to pay for a holiday to Antarctica. That's all gone horribly wrong, what with OPTI:Optibiotix being down after 5 years and Covid scuppering any chance of going on holiday anyway. Plus Antarctic trips cost about £16K so I'd need a lot more shares than 3,965.
I was thinking I should give up and move them into my ISA, but then I had a thought. These have been in an entirely separate account for years - and it's the account where I keep my trading shares. Why the hell haven't I been using this pot for trading?!
And so the decision has been made. As soon as these get into profit I'm going to start trading them, and push any profits into my SIPP so I can get the tax rebate and buy more OPTI. I'm kicking myself for not thinking of this 2 years ago!
Meanwhile I'm up past the £2,200 I need to be able to do a pension transfer, so I applied for it yesterday. I had intended to transfer it into my new AJ Bell SIPP, but their bloody useless website has no electronic transfer option. I had to print out a page, sign it and post it to them. My instant thought was "Bollocks to that!" and I did an electronic transfer from my Hargreaves Lansdown account. Afterwards I figured I was being a tad petulant, as the postage would only add a few days to the process. Next time I'll post the form.
The cash should appear in the account in around 3 weeks time, so I have to decide what to do with it. My instinct is to buy more OPTI:Optibiotix while they are so cheap, and I will do if they remain under 60p. My next instinct is to increase my SBTX:SkinBioTherapeutics holding, which I will do if they stay around 17p and OPTI go up.
However my other instinct is to get back into DDDD:4D Pharma as they have dropped back to 97p after I sold some of mine for 156p not that long ago. I would like to have some of these as I think they will be massive, but the thought of another 3 years before revenues start coming in is putting me off. They might be a good one to trade though.
The other option is to go back to my magic formula. This is a tempting option, but I do have 7 of these now in a portfolio of 12 shares. They are however nearly all in profit, so should I turn my back on them for more microbiome shares? I could be reaping regular dividends if I stick with the plan. If I go with this option, then the 2 shares I would buy are PLUS:Plus500 and PSN:Persimmon. Both of these make me nervous. I've been bitten by investing in house builders before, and if regulations tighten up on spread betting PLUS will potentially be in trouble. Having said that, regulations have tightened up and they still seem to be doing pretty well. I'd get a socking 8% dividend yield from PSN:Persimmon, and an acceptable 3% from PLUS:Plus500.
It's a difficult decision as the microbiome shares are all at a very tempting price right now. I guess I just wait until the cash arrives and see how I feel. This will be my rule:
If OPTI:Optibiotix less than 60p then buy - elseIf SBTX:SkinBioTherapeutics less than 17p then buy - else
If DDDD:4D Pharma less than 100p then buy - else
Buy PLUS:Plus500 and PSN:Persimmon
Can't say fairer than that!
No comments:
Post a Comment